| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1551147 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LAMA5 mRNA | CTD | PMID:17942748 |
| 17beta-hydroxy-5alpha-androstan-3-one | increases expression | ISO | RGD:1551147 | 6480464 | Dihydrotestosterone results in increased expression of LAMA5 mRNA | CTD | PMID:17023530 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1551147 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LAMA5 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of LAMA5 mRNA | CTD | PMID:22298810 |
| 2-methylcholine | affects expression | ISO | RGD:1354079 | 6480464 | beta-methylcholine affects the expression of LAMA5 mRNA | CTD | PMID:21179406 |
| 2-nitrofluorene | increases expression | EXP | | 6480464 | 2-nitrofluorene results in increased expression of LAMA5 mRNA | CTD | PMID:22484513 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases expression | EXP | | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of LAMA5 mRNA | CTD | PMID:22484513 |
| aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of LAMA5 mRNA | CTD | PMID:22484513 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1354079 | 6480464 | Tretinoin results in increased expression of LAMA5 mRNA | CTD | PMID:17138961 |
| anthracen-2-amine | increases expression | EXP | | 6480464 | 2-anthramine results in increased expression of LAMA5 mRNA | CTD | PMID:23038007 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1354079 | 6480464 | Benzo(a)pyrene results in decreased expression of LAMA5 mRNA | CTD | PMID:20106945 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1354079 | 6480464 | Benzo(a)pyrene results in decreased expression of LAMA5 mRNA | CTD | PMID:20106945 PMID:21632981 |
| bis(2-chloroethyl) sulfide | decreases expression | ISO | RGD:1354079 | 6480464 | Mustard Gas results in decreased expression of LAMA5 protein | CTD | PMID:12880345 |
| carbonyl sulfide | increases expression | EXP | | 6480464 | carbonyl sulfide results in increased expression of LAMA5 mRNA | CTD | PMID:19395590 |
| choline | multiple interactions | ISO | RGD:1551147 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LAMA5 mRNA | CTD | PMID:20938992 |
| cobalt dichloride | decreases secretion | ISO | RGD:1354079 | 6480464 | cobaltous chloride results in decreased secretion of LAMA5 protein | CTD | PMID:22079246 |
| copper(2+) sulfate | increases expression | ISO | RGD:1551147 | 6480464 | Copper Sulfate results in increased expression of LAMA5 mRNA | CTD | PMID:18579281 |
| dexamethasone | decreases expression | EXP | | 6480464 | Dexamethasone results in decreased expression of LAMA5 mRNA | CTD | PMID:20032058 |
| dexamethasone | multiple interactions | EXP | | 6480464 | Testosterone inhibits the reaction [Dexamethasone results in decreased expression of LAMA5 mRNA] | CTD | PMID:20032058 |
| diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of LAMA5 mRNA | CTD | PMID:21551480 |
| folic acid | multiple interactions | ISO | RGD:1551147 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LAMA5 mRNA | CTD | PMID:20938992 |
| hydrogen peroxide | affects expression | ISO | RGD:1354079 | 6480464 | Hydrogen Peroxide affects the expression of LAMA5 mRNA | CTD | PMID:21179406 |
| L-methionine | multiple interactions | ISO | RGD:1551147 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LAMA5 mRNA | CTD | PMID:20938992 |
| lead diacetate | increases expression | ISO | RGD:1551147 | 6480464 | lead acetate results in increased expression of LAMA5 mRNA | CTD | PMID:22609695 |
| menadione | affects expression | ISO | RGD:1354079 | 6480464 | Vitamin K 3 affects the expression of LAMA5 mRNA | CTD | PMID:20044591 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of LAMA5 mRNA | CTD | PMID:18164116 |
| paracetamol | affects expression | ISO | RGD:1551147 | 6480464 | Acetaminophen affects the expression of LAMA5 mRNA | CTD | PMID:17562736 |
| pirinixic acid | multiple interactions | ISO | RGD:1354079 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of LAMA5 mRNA | CTD | PMID:19710929 |
| retinyl acetate | increases expression | ISO | RGD:1551147 | 6480464 | retinol acetate results in increased expression of LAMA5 mRNA | CTD | PMID:16772331 |
| tamoxifen | affects expression | ISO | RGD:1354079 | 6480464 | Tamoxifen affects the expression of LAMA5 mRNA | CTD | PMID:14699072 |
| tert-butyl hydroperoxide | decreases expression | ISO | RGD:1354079 | 6480464 | tert-Butylhydroperoxide results in decreased expression of LAMA5 mRNA | CTD | PMID:15336504 |
| testosterone | multiple interactions | EXP | | 6480464 | Testosterone inhibits the reaction [Dexamethasone results in decreased expression of LAMA5 mRNA] | CTD | PMID:20032058 |
| tetrachloromethane | affects expression | ISO | RGD:1551147 | 6480464 | Carbon Tetrachloride affects the expression of LAMA5 mRNA | CTD | PMID:17484886 |
| zalcitabine | multiple interactions | EXP | | 6480464 | [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in increased expression of LAMA5 mRNA | CTD | PMID:18606552 |
| zinc atom | increases expression | ISO | RGD:1354079 | 6480464 | Zinc deficiency results in increased expression of LAMA5 mRNA | CTD | PMID:22171008 |
| zinc(0) | increases expression | ISO | RGD:1354079 | 6480464 | Zinc deficiency results in increased expression of LAMA5 mRNA | CTD | PMID:22171008 |
| zoledronic acid | multiple interactions | ISO | RGD:1354079 | 6480464 | [zoledronic acid co-treated with Gossypol] results in decreased expression of LAMA5 mRNA | CTD | PMID:19825521 |